Details about John Brazier

Access statistics for papers by John Brazier.

Last updated 2019-03-05. Update your information in the RePEc Author Service.

Short-id: pbr766

Working Papers

2010

1. A review and meta-analysis of health state utility values in breast cancer
   MPRA Paper, University Library of Munich, Germany View citations (17)
2. Developing a health state classification system from NEWQOL for epilepsy using classical psychometric techniques and Rasch analysis: a technical report
   MPRA Paper, University Library of Munich, Germany
3. Using a discrete choice experiment to estimate societal health state utility values
   MPRA Paper, University Library of Munich, Germany View citations (2)
4. Using health state utility values from the general population to approximate baselines in decision analytic models when condition specific data are not available
   MPRA Paper, University Library of Munich, Germany

2009

5. A qualitative study exploring the general population’s perception of rheumatoid arthritis after being informed about disease adaptation
   MPRA Paper, University Library of Munich, Germany View citations (1)
6. Measuring the value of life: exploring a new method for deriving the monetary value of a QALY
   MPRA Paper, University Library of Munich, Germany View citations (1)
7. Populating an economic model with health state utility values: moving towards better practice
   MPRA Paper, University Library of Munich, Germany
8. The impact of losses in income due to ill health: does the EQ-5D reflect lost earnings?
   MPRA Paper, University Library of Munich, Germany View citations (2)
9. The simultaneous valuation of states from multiple instruments using ranking and VAS data: methods and preliminary results
   MPRA Paper, University Library of Munich, Germany View citations (1)
10. Using Rasch analysis to form plausible health states amenable to valuation: the development of CORE-6D from CORE-OM in order to elicit preferences for common mental health problems
    MPRA Paper, University Library of Munich, Germany View citations (1)
11. Using rank and discrete choice data to estimate health state utility values on the QALY scale
    MPRA Paper, University Library of Munich, Germany View citations (2)

2008

12. A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures
    MPRA Paper, University Library of Munich, Germany View citations (1)
13. Combining Rasch and cluster analysis: a novel method for developing rheumatoid arthritis states for use in valuation studies
    MPRA Paper, University Library of Munich, Germany View citations (1)
14. Making Rasch decisions: the use of Rasch analysis in the construction of preference based health related quality of life instruments
    MPRA Paper, University Library of Munich, Germany View citations (2)
15. Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
    MPRA Paper, University Library of Munich, Germany View citations (14)

2007

16. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method
    MPRA Paper, University Library of Munich, Germany
17. Estimating a preference-based single index from the Asthma Quality of Life Questionnaire (AQLQ)
    MPRA Paper, University Library of Munich, Germany View citations (1)
18. The use of Rasch analysis as a tool in the construction of a preference based measure: the case of AQLQ
    MPRA Paper, University Library of Munich, Germany View citations (2)
19. Valuing EQ-5D health states: A review and analysis, CHERE Working Paper 2007/9
    Working Papers, CHERE, University of Technology, Sydney View citations (11)

2006

20. An Internet “Value of Health” panel: recruitment, participation and compliance
    MPRA Paper, University Library of Munich, Germany
21. Does the National Institute for Health and Clinical Excellence take account of factors such as uncertainty and equity as well as incremental cost-effectiveness in commissioning health care services? A binary choice experiment
    MPRA Paper, University Library of Munich, Germany View citations (1)
22. Estimation of a preference based single index from the sexual quality of life questionnaire (SQOL) using ordinal data
    MPRA Paper, University Library of Munich, Germany

2005

23. Current state of the art in preference-based measures of health and avenues for further research
    MPRA Paper, University Library of Munich, Germany View citations (1)
24. Evidence of preference construction in a comparison of variants of the standard gamble method
    MPRA Paper, University Library of Munich, Germany

2004

25. Estimating population cardinal health state valuation models from individual ordinal (rank) health state preference data
    MPRA Paper, University Library of Munich, Germany View citations (1)

2002

26. Deriving preference-based single indices from non-preference based condition-specific instruments: converting AQLQ into EQ5D indices
    MPRA Paper, University Library of Munich, Germany View citations (16)
27. Sample sizes for the SF-6D preference based measure of health from the SF-36: a practical guide
    MPRA Paper, University Library of Munich, Germany View citations (6)

2001

28. Quality of life evidence for patients with Alzheimer’s disease: use of existing quality of life evidence from the ADENA trials to estimate the utility impact of Exelon®
    MPRA Paper, University Library of Munich, Germany

1988

29. Internal markets in the National Health Service: a review of the economic issues
    Working Papers, Centre for Health Economics, University of York
30. Reforming the UK health care system: as framework for analysis and a review of some recent proposals
    Working Papers, Centre for Health Economics, University of York View citations (1)

Journal Articles

2019

1. A Qualitative Study of the Views of Health and Social Care Decision-Makers on the Role of Wellbeing in Resource Allocation Decisions in the UK
   Economies, 2019, 7, (1), 1-13 View citations (3)
2. Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
   PharmacoEconomics, 2019, 37, (3), 293-299 View citations (1)

2018

3. 3L, 5L, What the L? A NICE Conundrum
   PharmacoEconomics, 2018, 36, (6), 637-640 View citations (2)
4. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30
   PharmacoEconomics, 2018, 36, (2), 225-238 View citations (4)
5. Correction to: 3L, 5L, What the L? A NICE Conundrum
   PharmacoEconomics, 2018, 36, (6), 729-729 View citations (2)
6. EQ‐5D‐5L: Smaller steps but a major step change?
   Health Economics, 2018, 27, (1), 4-6 View citations (1)
7. Estimating an exchange rate between the EQ-5D-3L and ASCOT
   The European Journal of Health Economics, 2018, 19, (5), 653-661 View citations (1)
8. Experience-based utility and own health state valuation for a health state classification system: why and how to do it
   The European Journal of Health Economics, 2018, 19, (6), 881-891 View citations (5)
9. Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15
   The Patient: Patient-Centered Outcomes Research, 2018, 11, (1), 29-37

2017

10. A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models
    PharmacoEconomics, 2017, 35, (1), 21-31 View citations (12)
11. Estimating Health State Utility Values for Comorbidities
    PharmacoEconomics, 2017, 35, (1), 89-94 View citations (2)
12. How do individuals value health states? A qualitative investigation
    Social Science & Medicine, 2017, 172, (C), 80-88 View citations (7)
13. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?
    PharmacoEconomics, 2017, 35, (4), 439-451 View citations (3)
14. Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies
    PharmacoEconomics, 2017, 35, (1), 67-75
15. Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care
    PharmacoEconomics, 2017, 35, (1), 7-9 View citations (2)
16. The Identification, Review and Synthesis of Health State Utility Values from the Literature
    PharmacoEconomics, 2017, 35, (1), 43-55 View citations (4)
17. The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment
    PharmacoEconomics, 2017, 35, (1), 33-41 View citations (8)
18. The Use of Health State Utility Values in Decision Models
    PharmacoEconomics, 2017, 35, (1), 77-88 View citations (2)

2016

19. Comparison of Modes of Administration and Alternative Formats for Eliciting Societal Preferences for Burden of Illness
    Applied Health Economics and Health Policy, 2016, 14, (1), 89-104 View citations (6)
20. Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?
    PharmacoEconomics, 2016, 34, (7), 645-649 View citations (49)
21. Nothing About Us Without Us? A Comparison of Adolescent and Adult Health‐State Values for the Child Health Utility‐9D Using Profile Case Best–Worst Scaling
    Health Economics, 2016, 25, (4), 486-496 View citations (11)
22. Valuing the Child Health Utility 9D: Using profile case best worst scaling methods to develop a new adolescent specific scoring algorithm
    Social Science & Medicine, 2016, 157, (C), 48-59 View citations (14)

2015

23. EQ-5D in skin conditions: an assessment of validity and responsiveness
    The European Journal of Health Economics, 2015, 16, (9), 927-939 View citations (2)
24. Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample
    The European Journal of Health Economics, 2015, 16, (2), 141-151 View citations (4)
25. Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY
    Applied Health Economics and Health Policy, 2015, 13, (6), 557-565 View citations (22)
26. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    PharmacoEconomics, 2015, 33, (11), 1101-1105 View citations (2)
27. Valuing Child Health Utility 9D Health States with Young Adults: Insights from a Time Trade Off Study
    Applied Health Economics and Health Policy, 2015, 13, (5), 485-492 View citations (11)

2014

28. AN AUSTRALIAN DISCRETE CHOICE EXPERIMENT TO VALUE EQ‐5D HEALTH STATES
    Health Economics, 2014, 23, (6), 729-742 View citations (25)
29. Health state utilities for skeletal-related events secondary to bone metastases
    The European Journal of Health Economics, 2014, 15, (1), 7-18 View citations (2)
30. Measuring quality of life in mental health: Are we asking the right questions?
    Social Science & Medicine, 2014, 120, (C), 12-20 View citations (9)

2013

31. Valuing the EQ-5D and the SF-6D health states using subjective well-being: A secondary analysis of patient data
    Social Science & Medicine, 2013, 77, (C), 97-105 View citations (21)

2012

32. Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale
    The European Journal of Health Economics, 2012, 13, (5), 575-587 View citations (6)
33. Developing Adolescent-Specific Health State Values for Economic Evaluation
    PharmacoEconomics, 2012, 30, (8), 713-727 View citations (9)
34. Does the EQ-5D Reflect Lost Earnings?
    PharmacoEconomics, 2012, 30, (1), 47-61 View citations (5)
35. Using a discrete choice experiment to estimate health state utility values
    Journal of Health Economics, 2012, 31, (1), 306-318 View citations (20)
36. Valuing states from multiple measures on the same visual analogue sale: a feasibility study
    Health Economics, 2012, 21, (6), 715-729 View citations (3)

2011

37. Best-worst scaling vs. discrete choice experiments: An empirical comparison using social care data
    Social Science & Medicine, 2011, 72, (10), 1717-1727 View citations (43)
38. Estimation of Utilities in Attention-Deficit Hyperactivity Disorder for Economic Evaluations
    The Patient: Patient-Centered Outcomes Research, 2011, 4, (4), 247-257 View citations (1)
39. The impact of adding an extra dimension to a preference-based measure
    Social Science & Medicine, 2011, 73, (2), 245-253 View citations (5)
40. Understanding the effect of disease adaptation information on general population values for hypothetical health states
    Social Science & Medicine, 2011, 72, (11), 1904-1912 View citations (11)
41. Valuing child health utility 9D health states with a young adolescent sample
    Applied Health Economics and Health Policy, 2011, 9, (1), 15-27 View citations (17)

2010

42. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures
    The European Journal of Health Economics, 2010, 11, (2), 215-225 View citations (38)

2007

43. A comparison of patient and population values for health states in varicose veins patients
    Health Economics, 2007, 16, (4), 395-405 View citations (6)
44. Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?
    Health Economics, 2007, 16, (6), 645-647 View citations (3)
45. Modelling SF-6D health state preference data using a nonparametric Bayesian method
    Journal of Health Economics, 2007, 26, (3), 597-612 View citations (15)
46. Modelling covariates for the SF-6D standard gamble health state preference data using a nonparametric Bayesian method
    Social Science & Medicine, 2007, 64, (6), 1242-1252 View citations (11)
47. Multi-attribute utility function or statistical inference models: A comparison of health state valuation models using the HUI2 health state classification system
    Journal of Health Economics, 2007, 26, (5), 992-1002 View citations (5)

2006

48. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets
    Journal of Health Economics, 2006, 25, (2), 334-346 View citations (13)
49. Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion
    Health Economics, 2006, 15, (1), 1-4 View citations (18)
50. Does the whole equal the sum of the parts? Patient‐assigned utility scores for IBS‐related health states and profiles
    Health Economics, 2006, 15, (6), 543-551 View citations (6)
51. Erratum to ‘Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey’ Health Economics 2005; 14(3): 231–244
    Health Economics, 2006, 15, (7), 761-761 View citations (1)
52. Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey
    Health Economics, 2006, 15, (5), 527-533 View citations (4)
53. Using rank data to estimate health state utility models
    Journal of Health Economics, 2006, 25, (3), 418-431 View citations (29)

2005

54. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis
    Social Science & Medicine, 2005, 60, (7), 1571-1582 View citations (30)
55. Description of an individual patient methodology for calculating the cost-effectiveness of treatments for osteoporosis in women
    Journal of the Operational Research Society, 2005, 56, (2), 214-221 View citations (3)
56. Estimating utilities from individual health preference data: a nonparametric Bayesian method
    Journal of the Royal Statistical Society Series C, 2005, 54, (5), 879-895 View citations (18)
57. Health state values for the HUI 2 descriptive system: results from a UK survey
    Health Economics, 2005, 14, (3), 231-244 View citations (23)
58. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
    Health Economics, 2005, 14, (4), 339-347 View citations (73)

2004

59. A comparison of the EQ‐5D and SF‐6D across seven patient groups
    Health Economics, 2004, 13, (9), 873-884 View citations (56)

2003

60. A view from the bridge: agreement between the SF‐6D utility algorithm and the Health Utilities Index
    Health Economics, 2003, 12, (11), 975-981 View citations (14)

2002

61. Measures of health‐related quality of life in an imperfect world: a comment on Dowie
    Health Economics, 2002, 11, (1), 17-19 View citations (3)
62. The estimation of a preference-based measure of health from the SF-36
    Journal of Health Economics, 2002, 21, (2), 271-292 View citations (268)

1999

63. A checklist for judging preference‐based measures of health related quality of life: Learning from psychometrics
    Health Economics, 1999, 8, (1), 41-51 View citations (34)

1995

64. Introduction
    Social Science & Medicine, 1995, 41, (10), 1337-1338
65. The use of condition specific outcome measures in economic appraisal
    Health Economics, 1995, 4, (4), 255-264 View citations (5)

1993

66. The SF‐36 health survey questionnaire—a tool for economists
    Health Economics, 1993, 2, (3), 213-215 View citations (1)

1991

67. An Economic Review of the NHS White Paper
    Scottish Journal of Political Economy, 1991, 38, (1), 96-105

Books

2016

1. Measuring and Valuing Health Benefits for Economic Evaluation
   OUP Catalogue, Oxford University Press View citations (25)
   Also in OUP Catalogue, Oxford University Press (2007) View citations (127)

Chapters

2012

1. Methods for Developing Preference-based Measures of Health
   Chapter 37 in The Elgar Companion to Health Economics, Second Edition, 2012
   Also in Chapter 35 in The Elgar Companion to Health Economics, 2006 (2006)